Metformin
Metformin is a pharmaceutical drug with 1,289 clinical trials. Currently 108 active trials ongoing. Historical success rate of 89.1%.
Success Metrics
Based on 814 completed trials
Phase Distribution
Phase Distribution
248
Early Stage
294
Mid Stage
574
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.0%
814 of 958 finished
15.0%
144 ended early
108
trials recruiting
1,289
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Drug-Drug Interaction Study of Atumelnant in Healthy Participants
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)
Clinical Trials (1,289)
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Drug-Drug Interaction Study of Atumelnant in Healthy Participants
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)
Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction
A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer
Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
Intertrochanteric Femur Fracture Patients Who Receive Metformin With a Placebo
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Antecedent Metabolic Health and Metformin Aging Study
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes
Improve PAD PERformance With METformin
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 1,289